Gennex Laboratories Limited (BOM:531739)
India · Delayed Price · Currency is INR 10.71
-0.09 (-0.83%)
At close: Jun 16, 2026
Gennex Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 209.79 | 181.23 | 131.75 | 49.21 | 39.23 |
Depreciation & Amortization | 26.48 | 19.91 | 23.68 | 9.19 | 7.88 |
Other Operating Activities | -28.88 | -59.06 | 25.98 | 1.45 | 20.2 |
Change in Accounts Receivable | -293.95 | 36.5 | -83.95 | 18.97 | -23.67 |
Change in Inventory | -179.48 | -107.65 | -94.83 | -79.56 | -27.18 |
Change in Accounts Payable | 7.35 | -20.21 | 20.5 | 124.46 | 54.74 |
Change in Other Net Operating Assets | -377.86 | -158.68 | -490 | 113.04 | 47.88 |
Operating Cash Flow | -636.54 | -107.97 | -466.86 | 236.76 | 119.08 |
Operating Cash Flow Growth | - | - | - | 98.82% | - |
Capital Expenditures | -119.37 | -89.47 | - | -397.86 | -15.94 |
Sale of Property, Plant & Equipment | - | 2 | 153.53 | 0.5 | 0.29 |
Investment in Securities | - | - | -2.34 | -12.54 | - |
Other Investing Activities | 71.38 | 95.71 | 37.95 | 26.61 | -9 |
Investing Cash Flow | -47.99 | 8.24 | 189.13 | -383.29 | -24.66 |
Short-Term Debt Issued | 265.47 | 44.98 | - | - | 27.62 |
Long-Term Debt Issued | 257.35 | 36.77 | - | 10.18 | - |
Total Debt Issued | 522.82 | 81.75 | - | 10.18 | 27.62 |
Short-Term Debt Repaid | - | - | - | -90.7 | - |
Long-Term Debt Repaid | - | - | -30.72 | - | -37.15 |
Total Debt Repaid | - | - | -30.72 | -90.7 | -37.15 |
Net Debt Issued (Repaid) | 522.82 | 81.75 | -30.72 | -80.52 | -9.54 |
Issuance of Common Stock | 172.18 | - | 798.32 | 304.39 | - |
Other Financing Activities | -41.98 | -36.08 | -30.76 | -13.54 | -8.77 |
Financing Cash Flow | 653.02 | 45.67 | 736.84 | 210.33 | -18.31 |
Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - |
Net Cash Flow | -31.51 | -54.06 | 459.11 | 63.81 | 76.11 |
Free Cash Flow | -755.91 | -197.44 | -466.86 | -161.1 | 103.14 |
Free Cash Flow Margin | -43.76% | -14.32% | -53.84% | -24.56% | 16.85% |
Free Cash Flow Per Share | -2.75 | -0.85 | -2.15 | -1.04 | 0.81 |
Cash Interest Paid | 41.98 | 36.08 | 30.76 | 13.54 | 8.77 |
Cash Income Tax Paid | 22.59 | 32.2 | - | - | 11.1 |
Levered Free Cash Flow | -831.33 | -250.11 | -511.57 | -175.84 | 17.82 |
Unlevered Free Cash Flow | -805.09 | -227.56 | -492.34 | -167.38 | 23.3 |
Change in Working Capital | -843.93 | -250.04 | -648.27 | 176.91 | 51.77 |